Proposed Collection; Comment Request Evaluation of the Impact of the New Conflicts of Interest Regulations on the National Institutes of Health's Ability To Recruit and Retain Staff, 4922-4923 [06-845]
Download as PDF
<![CDATA[
4922
Federal Register / Vol. 71, No. 19 / Monday, January 30, 2006 / Notices
Dated: January 20, 2006.
Jason Brodsky,
Acting Associate Commissioner for External
Relations.
[FR Doc. E6–1069 Filed 1–27–06; 8:45 am]
BILLING CODE 4160–01–S
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
Blood Products Advisory Committee;
Notice of Meeting
AGENCY:
Food and Drug Administration,
HHS.
cprice-sewell on PROD1PC66 with NOTICES
ACTION:
Notice.
This notice announces a forthcoming
meeting of a public advisory committee
of the Food and Drug Administration
(FDA). At least one portion of the
meeting will be closed to the public.
Name of Committee: Blood Products
Advisory Committee.
General Function of the Committee:
To provide advice and
recommendations to the agency on
FDA’s regulatory issues.
Date and Time: The meeting will be
held on March 9, 2006, from 8 a.m. to
5 p.m. and March 10, 2006, from 8:30
a.m. to 4:30 p.m.
Location: Hilton Hotel Washington
DC North/ Gaithersburg, 620 Perry
Pkwy., Gaithersburg, MD 20877.
Contact Person: Donald W. Jehn, or
Pearline K. Muckelvene, Center for
Biologics Evaluation and Research
(HFM–71), Food and Drug
Administration, 1401 Rockville Pike,
Rockville, MD 20852, 301–827–0314, or
FDA Advisory Committee Information
Line, 1–800–741–8138 (301–443–0572
in the Washington, DC area), code
3014519516. Please call the Information
Line for up-to-date information on this
meeting.
Agenda: On March 9, 2006, in the
morning the committee will hear
updates on the following topics: (1)
Summary of the Department of Health
and Human Services Advisory
Committee on Blood Safety and
Availability January 2006 meeting; (2)
current considerations for blood donor
screening for West Nile Virus; (3)
classification of transfusion recipient
identification (ID) systems; and (4)
summary of the workshop on behaviorbased donor deferrals in the Nucleic
Acid Test (NAT) era. The committee
will then discuss rapid tests for
detection of bacterial contamination of
platelets. In the afternoon, the
committee will discuss public
comments on the ‘‘Guidance for
Industry and FDA Review Staff:
VerDate Aug<31>2005
14:07 Jan 27, 2006
Jkt 208001
Collection of Platelets by Automated
Methods (DRAFT).’’ On March 10, 2006,
in the morning the committee will
discuss proposed studies to support the
approval of over-the-counter (OTC)
home-use human immunodeficiency
virus (HIV) test kits. In the afternoon,
the committee will hear an overview of
the research programs of the Office of
Blood Research and Review, Center for
Biologics Evaluation and Research
(CBER), as presented to a subcommittee
of the Blood Products Advisory
Committee during their site visit on July
22, 2005, and discuss a subcommittee
report in closed session. Additionally,
the committee will hear an overview of
the research programs in the Laboratory
of Biochemistry and Vascular Biology
and the Laboratory of Cellular
Hematology, Division of Hematology,
Office of Blood Research and Review,
CBER and in closed session discuss the
report from the laboratory site visit of
October 6, 2005.
Procedure: On March 9, 2006, the
meeting is open to the public. On March
10, 2006, from 8:30 a.m. to 3:15 p.m.
and again from 4:15 p.m. to 4:30 p.m.,
the meeting is open to the public.
Interested persons may present data,
information, or views, orally or in
writing, on issues pending before the
committee. Written submissions may be
made to the contact person by February
28, 2006. Oral presentations from the
public will be scheduled on March 9,
2006, between approximately 9:45 a.m.
to 11:30 a.m. and 2:30 p.m. to 3:30 p.m.
On March 10, 2006, oral presentations
from the public will be scheduled
between approximately 9:30 a.m. to
10:30 a.m. and 2:45 p.m. to 2:55 p.m.
Time allotted for each presentation may
be limited. Those desiring to make
formal oral presentations should notify
the contact person before February 28,
2006, and submit a brief statement of
the general nature of the evidence or
arguments they wish to present, the
names and addresses of proposed
participants, and an indication of the
approximate time requested to make
their presentation.
Closed Committee Deliberations: On
March 10, 2006, from 3:15 p.m. to 4:15
p.m., the meeting will be closed to
permit discussion where disclosure
would constitute a clearly unwarranted
invasion of personal privacy (5 U.S.C.
552b(c)(6)) and to permit discussion and
review of trade secret and/or
confidential information (5 U.S.C.
552b(c)(4)). The committee will discuss
a subcommittee’s report of the internal
research programs in the Office of Blood
Research and Review, CBER. In
addition, the committee will discuss the
site visit report for the Laboratory of
PO 00000
Frm 00033
Fmt 4703
Sfmt 4703
Biochemistry and Vascular Biology and
Laboratory of Cellular Hematology,
Division of Hematology, Office of Blood
Research and Review, CBER.
Following this closed session, the
committee will provide summarized
comments regarding the Office Site Visit
Report in an open public session.
Persons attending FDA’s advisory
committee meetings are advised that the
agency is not responsible for providing
access to electrical outlets.
FDA welcomes the attendance of the
public at its advisory committee
meetings and will make every effort to
accommodate persons with physical
disabilities or special needs. If you
require special accommodations due to
a disability, please contact Donald W.
Jehn or Pearline K. Muckelvene at least
7 days in advance of the meeting. Notice
of this meeting is given under the
Federal Advisory Committee Act (5
U.S.C. app. 2).
Dated: January 20, 2006.
Jason Brodsky,
Acting Associate Commissioner for External
Relations.
[FR Doc. E6–1075 Filed 1–27–06; 8:45 am]
BILLING CODE 4160–01–S
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Proposed Collection; Comment
Request Evaluation of the Impact of
the New Conflicts of Interest
Regulations on the National Institutes
of Health’s Ability To Recruit and
Retain Staff
Summary: In compliance with the
requirement of Section 3506(c)(2)(A) of
the Paperwork Reduction Act of 1995,
for opportunity for public comment on
proposed data collection projects, the
Office of Human Resources (OHR) of the
National Institutes of Health (NIH) will
publish periodic summaries of proposed
projects to be submitted to the office of
Management and Budget (OMB) for
review and approval.
Proposed Collection
Title: Evaluation of the Impact of the
Conflicts of Interest Regulations on the
National Institutes of Health’s Ability to
Recruit and Retain Staff. Type of
Information Collection Request: New
Collection. Need and Use of Information
Collection: To assess the impact of new
Department of Health and Human
Services (HHS) ethics regulations on the
NIH’s ability to continue to attract and
recruit highly qualified scientific
personnel. This information collection
E:\FR\FM\30JAN1.SGM
30JAN1
cprice-sewell on PROD1PC66 with NOTICES
Federal Register / Vol. 71, No. 19 / Monday, January 30, 2006 / Notices
is essential to the mission of the NIH [42
U.S.C. 241 and 282(b)(1)]. In December
2003, the House Energy and Commerce
Committee raised concerns about
potential conflicts of interest at NIH. In
response to these concerns, the NIH
Director, Dr. Elias Zerhouni, ordered an
internal investigation into consulting
agreements at NIH and in June 2004
proposed changes to the agency’s
conflict-of-interest policies. Effective
February 3, 2005, the new regulations (5
CFR Parts 5501 and 5502,
‘‘Supplemental Standards of Ethical
Conduct and Financial Disclosure
Requirements for Employees of the
Department of Health and Human
Services,’’ FR Vol. 70, No. 22, Thursday,
February 3, 2005, 5543–5565, and Vol.
70, No. 168, Wednesday, August 31,
2005, 51559–51574) apply to all NIH
employees and, among other things,
place limits on certain financial
holdings of the most senior NIH
employees, their spouses, and minor
children and on certain outside
activities in which NIH staff may
engage. Gauging both the immediate and
longer term impact of these new rules is
crucial to NIH’s ability to develop and
maintain a world-class staff. This
project will produce data that will help
NIH and HHS leaders determine the
impact of the regulations and how to
minimize the effect of the regulations on
NIH’s ability to recruit and retain staff.
NIH intends to survey potential
applicants for NIH employment from
scientific organizations from which NIH
has traditionally drawn leading
scientific personnel, and those senior
scientists and administrators who have
voluntarily left NIH since February
2005. This will allow NIH to determine
whether the regulations impact
individuals’ attitudes about
employment at NIH and the likelihood
of their joining and/or leaving the
agency.
Frequency of Response: One time.
Affected Public: Individuals and
households. Type of Respondent: Highly
trained and qualified scientists engaged
in medicine and life sciences research.
The annual reporting burden is as
follows: Estimated Number of
Respondents: 500; Estimated Number of
Responses per Respondent: One;
Average Burden Hours Per Response: 15
minutes; and Estimated Total Annual
Burden Hours Requested: 117 hours.
The annualized cost to respondents is
estimated at $3,850. There are no
Capital Costs, Operating Costs, or
Maintenance Costs to report.
Request for Comments
Written comments and/or suggestions
from the public and affected agencies
VerDate Aug<31>2005
14:07 Jan 27, 2006
Jkt 208001
should address one or more of the
following points: (1) Evaluate whether
the proposed collection of information
is necessary for the proper performance
of the function of the agency, including
whether the information will have
practical utility; (2) Evaluate the
accuracy of the agency’s estimate of the
burden of the proposed collection of
information, including the validity of
the methodology and assumptions used;
(3) (enhance the quality, utility, and
clarity of the information to be
collected; and (4) Minimize the burden
of the collection of information on those
who are to respond, including the use
of appropriate automated electronic,
mechanical, or other technological
collection techniques or other forms of
information technology.
Comments Due Date
Comments regarding this information
collection are best assured of having
their full effect if received within 60
days of the date of this publication.
For More Information or to Direct
Comments: To submit comments, to
request more information on the
proposed project, or to obtain a copy of
the data collection plans and
instruments, contact Mr. Richard M.
Taffet, Acting Director, Client Services
Division; Office of Human Resources,
Office of the Director, National
Institutes of Health, Room 2–D234, East
Jefferson Street, Bethesda, MD 20892–
8502, or call the non-toll-free number
(301) 402–6627, or e-mail your
comments or request, including your
address, to: taffetr@mail.nih.gov.
Dated: January 23, 2006.
Raynard S. Kington,
Deputy Director, National Institutes of Health.
[FR Doc. 06–845 Filed 1–27–06; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of
Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The contract proposals and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
PO 00000
Frm 00034
Fmt 4703
Sfmt 4703
4923
and personal information concerning
individuals associated with the contract
proposals, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Cancer
Institute Special Emphasis Panel, SBIR Topic
208 (Phase I) ‘‘Targetry Systems for
Production of Research Radionucleides’’.
Date: February 23, 2006.
Time: 12 p.m. to 4 p.m.
Agenda: To review and evaluate contract
proposals.
Place: National Institutes of Health, 6116
Executive Boulevard, Rockville, MD 20852,
(Telephone Conference Call).
Contact Person: C. Michael Kerwin, PhD,
MPH, Scientific Review Administrator,
Special Review and Logistics Branch,
Division of Extramural Activities, National
Cancer Institute, National Institutes of
Health, 6116 Executive Boulevard, Room
8057, MSC 8329, Bethesda, MD 20892–8329,
301–496–7421, kerwinm@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.392, Cancer Construction;
93.393, Cancer Cause and Prevention
Research; 93.394, Cancer Detection and
Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology
Research; 93.397, Cancer Centers Support;
93.398, Cancer Research Manpower; 93.399,
Cancer Control, National Institutes of Health,
HHS)
Dated: January 23, 2006.
Anna Snouffer,
Acting Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 06–846 Filed 1–27–06; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of
Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The contract proposals and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the contract
proposals, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Cancer
Institute Special Emphasis Panel, SBIR Topic
207 (Phase I) ‘‘Synthesis Modules for
Radiopharmaceutical Production’’.
E:\FR\FM\30JAN1.SGM
30JAN1
]]>Agencies
[Federal Register Volume 71, Number 19 (Monday, January 30, 2006)]
[Notices]
[Pages 4922-4923]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 06-845]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Proposed Collection; Comment Request Evaluation of the Impact of
the New Conflicts of Interest Regulations on the National Institutes of
Health's Ability To Recruit and Retain Staff
Summary: In compliance with the requirement of Section
3506(c)(2)(A) of the Paperwork Reduction Act of 1995, for opportunity
for public comment on proposed data collection projects, the Office of
Human Resources (OHR) of the National Institutes of Health (NIH) will
publish periodic summaries of proposed projects to be submitted to the
office of Management and Budget (OMB) for review and approval.
Proposed Collection
Title: Evaluation of the Impact of the Conflicts of Interest
Regulations on the National Institutes of Health's Ability to Recruit
and Retain Staff. Type of Information Collection Request: New
Collection. Need and Use of Information Collection: To assess the
impact of new Department of Health and Human Services (HHS) ethics
regulations on the NIH's ability to continue to attract and recruit
highly qualified scientific personnel. This information collection
[[Page 4923]]
is essential to the mission of the NIH [42 U.S.C. 241 and 282(b)(1)].
In December 2003, the House Energy and Commerce Committee raised
concerns about potential conflicts of interest at NIH. In response to
these concerns, the NIH Director, Dr. Elias Zerhouni, ordered an
internal investigation into consulting agreements at NIH and in June
2004 proposed changes to the agency's conflict-of-interest policies.
Effective February 3, 2005, the new regulations (5 CFR Parts 5501 and
5502, ``Supplemental Standards of Ethical Conduct and Financial
Disclosure Requirements for Employees of the Department of Health and
Human Services,'' FR Vol. 70, No. 22, Thursday, February 3, 2005, 5543-
5565, and Vol. 70, No. 168, Wednesday, August 31, 2005, 51559-51574)
apply to all NIH employees and, among other things, place limits on
certain financial holdings of the most senior NIH employees, their
spouses, and minor children and on certain outside activities in which
NIH staff may engage. Gauging both the immediate and longer term impact
of these new rules is crucial to NIH's ability to develop and maintain
a world-class staff. This project will produce data that will help NIH
and HHS leaders determine the impact of the regulations and how to
minimize the effect of the regulations on NIH's ability to recruit and
retain staff. NIH intends to survey potential applicants for NIH
employment from scientific organizations from which NIH has
traditionally drawn leading scientific personnel, and those senior
scientists and administrators who have voluntarily left NIH since
February 2005. This will allow NIH to determine whether the regulations
impact individuals' attitudes about employment at NIH and the
likelihood of their joining and/or leaving the agency.
Frequency of Response: One time. Affected Public: Individuals and
households. Type of Respondent: Highly trained and qualified scientists
engaged in medicine and life sciences research. The annual reporting
burden is as follows: Estimated Number of Respondents: 500; Estimated
Number of Responses per Respondent: One; Average Burden Hours Per
Response: 15 minutes; and Estimated Total Annual Burden Hours
Requested: 117 hours. The annualized cost to respondents is estimated
at $3,850. There are no Capital Costs, Operating Costs, or Maintenance
Costs to report.
Request for Comments
Written comments and/or suggestions from the public and affected
agencies should address one or more of the following points: (1)
Evaluate whether the proposed collection of information is necessary
for the proper performance of the function of the agency, including
whether the information will have practical utility; (2) Evaluate the
accuracy of the agency's estimate of the burden of the proposed
collection of information, including the validity of the methodology
and assumptions used; (3) (enhance the quality, utility, and clarity of
the information to be collected; and (4) Minimize the burden of the
collection of information on those who are to respond, including the
use of appropriate automated electronic, mechanical, or other
technological collection techniques or other forms of information
technology.
Comments Due Date
Comments regarding this information collection are best assured of
having their full effect if received within 60 days of the date of this
publication.
For More Information or to Direct Comments: To submit comments, to
request more information on the proposed project, or to obtain a copy
of the data collection plans and instruments, contact Mr. Richard M.
Taffet, Acting Director, Client Services Division; Office of Human
Resources, Office of the Director, National Institutes of Health, Room
2-D234, East Jefferson Street, Bethesda, MD 20892-8502, or call the
non-toll-free number (301) 402-6627, or e-mail your comments or
request, including your address, to: taffetr@mail.nih.gov.
Dated: January 23, 2006.
Raynard S. Kington,
Deputy Director, National Institutes of Health.
[FR Doc. 06-845 Filed 1-27-06; 8:45 am]
BILLING CODE 4140-01-M
